skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) a randomised, open-label, phase 3 study
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) a randomised, open-label, phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) a randomised, open-label, phase 3 study

Barbara Burtness Kevin J Harrington; Richard Greil; Denis Soulieres; Makoto Tahara; Gilberto de Castro Castro Junior; Amanda Psyrri; Neus Baste; Prakash Neupane; Ase Bratland

Lancet v. 394, n. 10212, p. 1915-1928, 2019

New York 2019

Acesso online. A biblioteca também possui exemplares impressos.

2
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma health-related quality-of-life results from KEYNOTE-048
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma health-related quality-of-life results from KEYNOTE-048
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma health-related quality-of-life results from KEYNOTE-048

Danny Rischin Kevin J Harrington; Richard Greil; Denis Soulieres; Makoto Tahara; Gilberto de Castro Castro Junior; Amanda Psyrri; Irene Brana; Prakash Neupane; Ase Bratland

Oral oncology v. 128, article ID 105815, 12p, 2022

Amsterdam 2022

Acesso online. A biblioteca também possui exemplares impressos.

3
Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048 subgroup analysis by programmed death Ligand-1 combined positive score
Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048 subgroup analysis by programmed death Ligand-1 combined positive score
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab alone or with chemotherapy for recurrent/metastatic had and neck squamous cell carcinoma in KEYNOTE-048 subgroup analysis by programmed death Ligand-1 combined positive score

Barbara Burtness Danny Rischin; Richard Greil; Denis Soulieres; Makoto Tahara; Gilberto de Castro Castro Junior; Amanda Psyrri; Irene Brana; Neus Baste; Prakash Neupane

Journal of clinical oncology v. 40, n. 21, p. 2321-2334, 2022

Philadelphia 2022

Acesso online. A biblioteca também possui exemplares impressos.

4
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer

Rinnerthaler, Gabriel ; Gampenrieder, Simon Peter ; Greil, Richard

International journal of molecular sciences, 2019-03, Vol.20 (5), p.1115 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
5
CAR T-Cell Therapy in Hematological Malignancies
CAR T-Cell Therapy in Hematological Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

CAR T-Cell Therapy in Hematological Malignancies

Haslauer, Theresa ; Greil, Richard ; Zaborsky, Nadja ; Geisberger, Roland

International journal of molecular sciences, 2021-08, Vol.22 (16), p.8996 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
6
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma

Bishop, Michael R. ; Dickinson, Michael ; Purtill, Duncan ; Barba, Pere ; Santoro, Armando ; Hamad, Nada ; Kato, Koji ; Sureda, Anna ; Greil, Richard ; Thieblemont, Catherine ; Morschhauser, Franck ; Janz, Martin ; Flinn, Ian ; Rabitsch, Werner ; Kwong, Yok-Lam ; Kersten, Marie J. ; Minnema, Monique C. ; Holte, Harald ; Chan, Esther H.L. ; Martinez-Lopez, Joaquin ; Müller, Antonia M.S. ; Maziarz, Richard T. ; McGuirk, Joseph P. ; Bachy, Emmanuel ; Le Gouill, Steven ; Dreyling, Martin ; Harigae, Hideo ; Bond, David ; Andreadis, Charalambos ; McSweeney, Peter ; Kharfan-Dabaja, Mohamed ; Newsome, Simon ; Degtyarev, Evgeny ; Awasthi, Rakesh ; del Corral, Christopher ; Andreola, Giovanna ; Masood, Aisha ; Schuster, Stephen J. ; Jäger, Ulrich ; Borchmann, Peter ; Westin, Jason R.

The New England journal of medicine, 2022-02, Vol.386 (7), p.629-639 [Periódico revisado por pares]

Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
T cells in multiple myeloma display features of exhaustion and senescence at the tumor site
Material Type:
Artigo 		Adicionar ao Meu Espaço

T cells in multiple myeloma display features of exhaustion and senescence at the tumor site

Zelle-Rieser, Claudia ; Thangavadivel, Shanmugapriya ; Biedermann, Rainer ; Brunner, Andrea ; Stoitzner, Patrizia ; Willenbacher, Ella ; Greil, Richard ; Jöhrer, Karin

Journal of hematology and oncology, 2016-11, Vol.9 (1), p.116-116, Article 116 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
8
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Gnant, Michael, Prof ; Pfeiler, Georg, MD ; Dubsky, Peter C, MD ; Hubalek, Michael, MD ; Greil, Richard, Prof ; Jakesz, Raimund, Prof ; Wette, Viktor, MD ; Balic, Marija, MD ; Haslbauer, Ferdinand, MD ; Melbinger, Elisabeth, MD ; Bjelic-Radisic, Vesna, MD ; Artner-Matuschek, Silvia, MD ; Fitzal, Florian, MD ; Marth, Christian, Prof ; Sevelda, Paul, MD ; Mlineritsch, Brigitte, MD ; Steger, Günther G, MD ; Manfreda, Diether, MD ; Exner, Ruth, MD ; Egle, Daniel, MD ; Bergh, Jonas, Prof ; Kainberger, Franz, MD ; Talbot, Susan, MSc ; Warner, Douglas, MD ; Fesl, Christian, PhD ; Singer, Christian F, Prof

The Lancet (British edition), 2015-08, Vol.386 (9992), p.433-443 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Gampenrieder, Simon Peter ; Rinnerthaler, Gabriel ; Tinchon, Christoph ; Petzer, Andreas ; Balic, Marija ; Heibl, Sonja ; Schmitt, Clemens ; Zabernigg, August Felix ; Egle, Daniel ; Sandholzer, Margit ; Singer, Christian Fridolin ; Roitner, Florian ; Hager, Christopher ; Andel, Johannes ; Hubalek, Michael ; Knauer, Michael ; Greil, Richard

Breast cancer research : BCR, 2021-12, Vol.23 (1), p.112-112, Article 112 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
10
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma

Magnes, Teresa ; Wagner, Sandro ; Kiem, Dominik ; Weiss, Lukas ; Rinnerthaler, Gabriel ; Greil, Richard ; Melchardt, Thomas

International journal of molecular sciences, 2021-05, Vol.22 (9), p.4981 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (965)
  2. Anais de Congresso  (13)
  3. Book Chapters  (11)
  4. Reports  (11)
  5. Imagens  (8)
  6. Conjunto de Dados  (6)
  7. Livros  (3)
  8. Resenhas  (3)
  9. magazinearticle  (1)
  10. Dissertações  (1)
  11. Web Resources  (1)
  12. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1996  (11)
  2. 1996Até2002  (45)
  3. 2003Até2009  (126)
  4. 2010Até2017  (406)
  5. Após 2017  (432)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.012)
  2. Japonês  (50)
  3. Alemão  (11)
  4. Russo  (4)
  5. Norueguês  (1)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Castro Junior, G
  2. Neupane, P
  3. Psyrri, A
  4. Tahara, M
  5. Greil, R

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Oncology
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.